Cyclo(Pro-Leu)

CAS No. 5654-86-4

Cyclo(Pro-Leu)( Cyclo(leucyloprolyl) | Cyclo-L-leu-L-pro | Cyclo-L-prolyl-L-leucine )

Catalog No. M29035 CAS No. 5654-86-4

Cyclo(Pro-Leu) has brine shrimp lethality.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 45 Get Quote
10MG 68 Get Quote
25MG 115 Get Quote
50MG 173 Get Quote
100MG 258 Get Quote
200MG 388 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Cyclo(Pro-Leu)
  • Note
    Research use only, not for human use.
  • Brief Description
    Cyclo(Pro-Leu) has brine shrimp lethality.
  • Description
    Cyclo(Pro-Leu) has brine shrimp lethality.
  • In Vitro
    Cyclo(Pro-Leu) (compound 7) (1.23 μg/mL-300 μg/mL; 48 h) has cytotoxic activity for HT-29, MCF-7, A375, K562, and NCM460 cell lines with IC50 values of 101.56 μM, 78.78 μM, 51.13 μM, 21.72 μM and 775.86 μM, respectively.
  • In Vivo
    ——
  • Synonyms
    Cyclo(leucyloprolyl) | Cyclo-L-leu-L-pro | Cyclo-L-prolyl-L-leucine
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    5654-86-4
  • Formula Weight
    210.27
  • Molecular Formula
    C11H18N2O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC(C)CC1NC(=O)C2CCCN2C1=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • GP2-114

    GP2-114 is a catecholamine motility mimetic that produces current-dependent cardiovascular effects when administered via transdermal iontophoresis and can be used to study coronary artery disease (CAD).

  • Syntide 2 (TFA) (108...

    Syntide 2 (TFA) is a Ca2+ and CaM dependent protein kinase II (CaMKII) substrate peptide that selectively inhibits the gibberellin (GA) response, leaving composition and slicoic acid regulatory events unaffected.

  • Lorundrostat

    Lorundrostat (MT-4129) is an aldosterone synthase inhibitor with antihypertensive activity that lowers systolic blood pressure.